A.R.T. Advisors’s GSK GSK Stock Holding History

A.R.T. Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-75,980	Closed	-$4.05M	–	1485
2019 Q3	$4.05M	Buy	75,980 +52,960	+230%	+$2.72M	0.2%	103
2019 Q2	$1.15M	Sell	23,020 -20,720	-47%	-$1.04M	0.07%	418
2019 Q1	$2.29M	Buy	+43,740	New	+$2.19M	0.14%	201
2018 Q4	–	Sell	-58,400	Closed	-$2.93M	–	1446
2018 Q3	$2.93M	Buy	+58,400	New	+$2.97M	0.13%	207
2017 Q4	–	Sell	-64,080	Closed	-$3.25M	–	1483
2017 Q3	$3.25M	Buy	64,080 +54,240	+551%	+$2.75M	0.17%	150
2017 Q2	$530K	Sell	9,840 -76,960	-89%	-$4.1M	0.03%	778
2017 Q1	$4.57M	Buy	+86,800	New	+$4.4M	0.21%	115
2015 Q2	–	Sell	-65,868	Closed	-$3.8M	–	1561
2015 Q1	$3.8M	Sell	65,868 -116,496	-64%	-$6.68M	0.13%	204
2014 Q4	$9.74M	Buy	182,364 +175,469	+2,545%	+$9.82M	0.36%	39
2014 Q3	$396K	Sell	6,895 -37,849	-85%	-$2.32M	0.02%	847
2014 Q2	$2.99M	Buy	44,744 +22,773	+104%	+$1.54M	0.16%	175
2014 Q1	$1.47M	Sell	21,971 -35,383	-62%	-$2.39M	0.08%	352
2013 Q4	$3.83M	Buy	57,354 +13,258	+30%	+$860K	0.2%	128
2013 Q3	$2.77M	Buy	+44,096	New	+$2.84M	0.15%	198

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

A.R.T. Advisors's GSK Position: Q4 2019 in Review

A.R.T. Advisors sold out of GSK (GSK) in Q4 2019, closing a stake of 75,980 shares — an estimated $4.05M sold.

A.R.T. Advisors first reported a position in GSK in Q3 2013 and held it in 14 quarters. The position peaked at $9.74M in Q4 2014. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

A.R.T. Advisors reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 75,980 GSK shares in Q4 2019, an estimated $4.05M.
A.R.T. Advisors first reported a position in GSK in Q3 2013 and held it in 14 quarters.
A.R.T. Advisors's GSK position peaked at $9.74M in Q4 2014.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.